A drug containing the marijuana derivative cannabidiol (CBD) was approved to treat seizures associated with tuberous sclerosis complex (TSC) in patients aged 1 year or older. TSC is a genetic disease that causes benign tumors to grow throughout the body. It affects 1 in 6000 people.
Jaklevic MC. CBD Drug Is Approved for a Third Form of Epilepsy. JAMA. 2020;324(11):1026. doi:10.1001/jama.2020.16782
Best of JAMA Network 2022
Customize your JAMA Network experience by selecting one or more topics from the list below.